Regulation of Glutamate Release by α7 Nicotinic Receptors: Differential Role in Methamphetamine-Induced Damage to Dopaminergic and Serotonergic Terminals
- 15 December 2010
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 336 (3), 900-907
- https://doi.org/10.1124/jpet.110.177287
Abstract
Regulation of glutamate release is an important underlying mechanism in mediating excitotoxic events such as damage to dopamine (DA) and serotonin (5-HT) neurons observed after exposure to methamphetamine (Meth). One way to regulate glutamate release may be through the modulation of α7 nicotinic acetylcholine (nACh) receptors. Meth administration is known to increase acetylcholine release; however, it is unknown whether Meth increases glutamate release and causes long-term damage to both DA and 5-HT terminals through the activation of α7 nACh receptors. To test this hypothesis, the α7 nACh receptor antagonist, methyllycaconitine (MLA), was administered before the administration of repeated doses of Meth while simultaneously monitoring extracellular striatal glutamate with in vivo microdialysis. In addition, the subsequent long-term decreases in markers of dopaminergic and serotonergic terminals, including DA reuptake transporter (DAT), serotonin reuptake transporter (SERT), vesicular monoamine transporter-2, vesicular DA, and vesicular 5-HT content in the rat striatum, were measured. The results show that MLA pretreatment prevented Meth-induced increases in striatal glutamate and protected against the subsequent long-term decreases in striatal DAT and vesicular DA content without affecting the hyperthermia produced by Meth. In contrast, the Meth-induced decreases in striatal SERT immunoreactivity and vesicular 5-HT content were not affected by MLA. This suggests that the α7 nACh receptor differentially mediates glutamate-dependent damage to DA but not 5-HT terminals in a manner that is independent of hyperthermia. Furthermore, antagonism of α7 nACh receptors may be a possible therapeutic strategy for decreasing extracellular glutamate and preventing the excitotoxic damage observed in other DA-related neurodegenerative disorders.Keywords
This publication has 41 references indexed in Scilit:
- Second‐by‐second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake ratsSynapse, 2009
- Rat neuronal nicotinic acetylcholine receptors containing α7 subunit: pharmacological properties of ligand binding and functionActa Pharmacologica Sinica, 2009
- Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulationToxicology and Applied Pharmacology, 2007
- A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamineJournal of Neurochemistry, 2007
- Methamphetamine‐induced spectrin proteolysis in the rat striatumJournal of Neurochemistry, 2006
- S-Thiolation of Tyrosine Hydroxylase by Reactive Nitrogen Species in the Presence of Cysteine or GlutathioneAntioxidants and Redox Signaling, 2005
- Microglial activation is a pharmacologically specific marker for the neurotoxic amphetaminesNeuroscience Letters, 2004
- The Effects of Methamphetamine on Serotonin Transporter ActivityJournal of Neurochemistry, 2002
- Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicalsBrain Research, 1995
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988